Free Trial
NASDAQ:PTHL

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) Stock Price, News & Analysis

$4.35 +0.19 (+4.57%)
(As of 11/15/2024 ET)

About Pheton Holdings Ltd Class A Ordinary Shares Stock (NASDAQ:PTHL)

Key Stats

Today's Range
$4.00
$4.40
50-Day Range
$3.35
$6.44
52-Week Range
$3.32
$6.45
Volume
142,644 shs
Average Volume
148,985 shs
Market Capitalization
$28.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.

Receive PTHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pheton Holdings Ltd Class A Ordinary Shares and its competitors with MarketBeat's FREE daily newsletter.

PTHL Stock News Headlines

See More Headlines

PTHL Stock Analysis - Frequently Asked Questions

Pheton Holdings Ltd Class A Ordinary Shares' stock was trading at $3.90 at the beginning of 2024. Since then, PTHL stock has increased by 11.5% and is now trading at $4.35.
View the best growth stocks for 2024 here
.

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) raised $11 million in an initial public offering on Thursday, September 5th 2024. The company issued 2,500,000 shares at $4.00-$5.00 per share. Cathay Securities acted as the underwriter for the IPO.

Pheton Holdings Ltd Class A Ordinary Shares' quiet period expired on Tuesday, October 15th. Pheton Holdings Ltd Class A Ordinary Shares had issued 2,250,000 shares in its IPO on September 5th. The total size of the offering was $9,000,000 based on an initial share price of $4.00. During Pheton Holdings Ltd Class A Ordinary Shares' quiet period, underwriters and any insiders involved in the IPO were prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Shares of PTHL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pheton Holdings Ltd Class A Ordinary Shares investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Today
11/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:PTHL
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$28.62 million
Optionable
N/A
Beta
N/A
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:PTHL) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners